ORIGINAL ARTICLE |
|
Year : 2009 | Volume
: 75
| Issue : 6 | Page : 579--582 |
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y Mehta1, Laxman M Prajapati2, Bharti Mittal3, Chaitanya G Joshi4, Jayesh J Sheth5, Dinesh B Patel6, Dinkar M Dave1, Ramesh K Goyal7
1 Dr. Rasiklal Shah Sarvajanik Hospital, Modasa 383315, India 2 Shri B. M. Shah College of Pharmaceutical Education and Research, Modasa 383315, India 3 Department of Molecular Biology, Krishna Institute of Medical Sciences, Hyderabad 500003, India 4 Deparment of Animal Biotechnology, Anand Agricultural University, Anand 388001, India 5 Institute of Human Genetics, Ahmedabad 380015, India 6 Deep Hospital, Modasa 383315, India 7 Department of Pharmacology, L M College of Pharmacy, Ahmedabad 380009, India
Correspondence Address:
Timir Y Mehta Dr. Rasiklal Shah Sarvajanik Hospital, Modasa - 383 315, Gujarat India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0378-6323.57718
Background: Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis are severe cutaneous reactions caused by certain drugs, including antiepileptic carbamazepine. A strong association has been reported between human leucocyte antigen (HLA)-B*1502 and carbamazepine-induced SJS in Han Chinese patients. European studies suggested that HLA-B*1502 is not a universal marker but is ethnicity-specific for Asians. Aim: To study the association between HLA-B*1502 and carbamazepine-induced SJS in Indian patients. Methods: Eight individuals who fulfilled the diagnostic criteria of SJS induced by carbamazepine were identified and HLA-B molecular typing was performed. HLA-B genotyping was carried out by polymerase chain reaction using sequence-specific primers. Results: Out of eight patients studied for genotype, six patients were found to have the HLA-B*1502 allele. Conclusion: This study suggests an association between HLA-B*1502 and carbamazepine-induced SJS in Indian patients.
[FULL TEXT] [PDF]*
|